CEDIE   05498
CENTRO DE INVESTIGACIONES ENDOCRINOLOGICAS "DR. CESAR BERGADA"
Unidad Ejecutora - UE
artículos
Título:
New perspectives in the diagnosis of pediatric male hypogonadism: the importance of AMH as a Sertoli cell marker
Autor/es:
GRINSPON R; REY RA
Revista:
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA
Editorial:
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Referencias:
Lugar: San Pablo; Año: 2011 vol. 55 p. 512 - 519
ISSN:
0004-2730
Resumen:
Sertoli cells are the most active cell population in the testis during infancy and childhood. In these
periods of life, hypogonadism can only be evidenced without stimulation tests, if Sertoli cell function
is assessed. AMH is a useful marker of prepubertal Sertoli cell activity and number. Serum AMH is
high from fetal life until mid-puberty. Testicular AMH production increases in response to FSH and is
potently inhibited by androgens. Serum AMH is undetectable in anorchidic patients. In primary or central
hypogonadism affecting the whole gonad and established in fetal life or childhood, serum AMH
is low. Conversely, when hypogonadism affects only Leydig cells (e.g. LHb mutations, LH/CG receptor
or steroidogenic enzyme defects), serum AMH is normal or high. In pubertal males with central hypogonadism,
AMH is low for Tanner stage (reflecting lack of FSH stimulus), but high for the age (indicating
lack of testosterone inhibitory effect). Treatment with FSH provokes an increase in serum AMH,
whereas hCG administration increases testosterone levels, which downregulate AMH. In conclusion,
assessment of serum AMH is helpful to evaluate gonadal function, without the need for stimulation
tests, and guides etiological diagnosis of pediatric male hypogonadism. Furthermore, serum AMH is
an excellent marker of FSH and androgen action on the testis.b mutations, LH/CG receptor
or steroidogenic enzyme defects), serum AMH is normal or high. In pubertal males with central hypogonadism,
AMH is low for Tanner stage (reflecting lack of FSH stimulus), but high for the age (indicating
lack of testosterone inhibitory effect). Treatment with FSH provokes an increase in serum AMH,
whereas hCG administration increases testosterone levels, which downregulate AMH. In conclusion,
assessment of serum AMH is helpful to evaluate gonadal function, without the need for stimulation
tests, and guides etiological diagnosis of pediatric male hypogonadism. Furthermore, serum AMH is
an excellent marker of FSH and androgen action on the testis.